These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 21643731)

  • 1. Pseudomonas siderophores in the sputum of patients with cystic fibrosis.
    Martin LW; Reid DW; Sharples KJ; Lamont IL
    Biometals; 2011 Dec; 24(6):1059-67. PubMed ID: 21643731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics of Pseudomonas aeruginosa Australian epidemic strain 1 (AES-1) cultured under conditions mimicking the cystic fibrosis lung reveals increased iron acquisition via the siderophore pyochelin.
    Hare NJ; Soe CZ; Rose B; Harbour C; Codd R; Manos J; Cordwell SJ
    J Proteome Res; 2012 Feb; 11(2):776-95. PubMed ID: 22054071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudomonas aeruginosa uses multiple pathways to acquire iron during chronic infection in cystic fibrosis lungs.
    Konings AF; Martin LW; Sharples KJ; Roddam LF; Latham R; Reid DW; Lamont IL
    Infect Immun; 2013 Aug; 81(8):2697-704. PubMed ID: 23690396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron acquisition by Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis.
    Lamont IL; Konings AF; Reid DW
    Biometals; 2009 Feb; 22(1):53-60. PubMed ID: 19130260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyoverdine and pyochelin measurements.
    Hoegy F; Mislin GL; Schalk IJ
    Methods Mol Biol; 2014; 1149():293-301. PubMed ID: 24818914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Siderophore synthesis by mucoid Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.
    Haas B; Murphy E; Castignetti D
    Can J Microbiol; 1991 Aug; 37(8):654-7. PubMed ID: 1835428
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Kang D; Xu Q; Kirienko NV
    Microbiol Spectr; 2024 Mar; 12(3):e0369323. PubMed ID: 38311809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis.
    Reid DW; Carroll V; O'May C; Champion A; Kirov SM
    Eur Respir J; 2007 Aug; 30(2):286-92. PubMed ID: 17504792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial cyanogenesis occurs in the cystic fibrosis lung.
    Sanderson K; Wescombe L; Kirov SM; Champion A; Reid DW
    Eur Respir J; 2008 Aug; 32(2):329-33. PubMed ID: 18480103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Siderophore presence in sputa of cystic fibrosis patients.
    Haas B; Kraut J; Marks J; Zanker SC; Castignetti D
    Infect Immun; 1991 Nov; 59(11):3997-4000. PubMed ID: 1834571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Pseudomonas aeruginosa pirA gene encodes a second receptor for ferrienterobactin and synthetic catecholate analogues.
    Ghysels B; Ochsner U; Möllman U; Heinisch L; Vasil M; Cornelis P; Matthijs S
    FEMS Microbiol Lett; 2005 May; 246(2):167-74. PubMed ID: 15899402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyoverdine siderophores: from biogenesis to biosignificance.
    Visca P; Imperi F; Lamont IL
    Trends Microbiol; 2007 Jan; 15(1):22-30. PubMed ID: 17118662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolutionary dynamics of interlinked public goods traits: an experimental study of siderophore production in Pseudomonas aeruginosa.
    Ross-Gillespie A; Dumas Z; Kümmerli R
    J Evol Biol; 2015 Jan; 28(1):29-39. PubMed ID: 25421271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa, cyanide accumulation and lung function in CF and non-CF bronchiectasis patients.
    Ryall B; Davies JC; Wilson R; Shoemark A; Williams HD
    Eur Respir J; 2008 Sep; 32(3):740-7. PubMed ID: 18480102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Iron Uptake Systems in Pseudomonas aeruginosa Virulence and Airway Infection.
    Minandri F; Imperi F; Frangipani E; Bonchi C; Visaggio D; Facchini M; Pasquali P; Bragonzi A; Visca P
    Infect Immun; 2016 Aug; 84(8):2324-2335. PubMed ID: 27271740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
    Kronborg G
    APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathogen
    Cunrath O; Graulier G; Carballido-Lopez A; Pérard J; Forster A; Geoffroy VA; Saint Auguste P; Bumann D; Mislin GLA; Michaud-Soret I; Schalk IJ; Fechter P
    Metallomics; 2020 Dec; 12(12):2108-2120. PubMed ID: 33355556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological properties of thiazole-analogues of pyochelin, a siderophore of Pseudomonas aeruginosa.
    Noël S; Hoegy F; Rivault F; Rognan D; Schalk IJ; Mislin GL
    Bioorg Med Chem Lett; 2014 Jan; 24(1):132-5. PubMed ID: 24332092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptation of iron homeostasis pathways by a Pseudomonas aeruginosa pyoverdine mutant in the cystic fibrosis lung.
    Nguyen AT; O'Neill MJ; Watts AM; Robson CL; Lamont IL; Wilks A; Oglesby-Sherrouse AG
    J Bacteriol; 2014 Jun; 196(12):2265-76. PubMed ID: 24727222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients.
    Bjarnsholt T; Jensen PØ; Fiandaca MJ; Pedersen J; Hansen CR; Andersen CB; Pressler T; Givskov M; Høiby N
    Pediatr Pulmonol; 2009 Jun; 44(6):547-58. PubMed ID: 19418571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.